Doxazosin mesylate structure
Doxazosin mesylate
Doxazosin mesylate(UK 33274) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.Target: α1-adrenergic receptorDoxazosin (mesylate) is the mesylate salt form of doxazosin, which is a long-lasting inhibitor of α1-adrenoceptors that is widely used to treat benign prostatic hyperplasia and lower urinary tract symptoms [1]. doxazosin may have a direct inhibitory effect on cholesterol synthesis independent of the LDL receptor. The inhibition of choles
Find 34 Related Holders
CIPLA LTD.
Brazil
Brazil
API Registration Country
API Inactive
-
Country:
Brazil -
Address:
VIKHROLI, EXTERIOR - EX
China CHINO PHARMA Ltd
China
China
API Registration Country
API Inactive
-
Founded in:
2021-08-10 -
Country:
China -
Address:
Room 402, No. 54, Lane 1277, Zhuanxing East Road, Minhang District, Shanghai -
Tax NO.:
91310112MA1GF2KC6D -
Registered Funds:
1 million yuan -
Website:
-
Email:
BASF PHARMACHEMIKALIEN GMBH CO KG
United States
United States
API Registration Country
API Inactive
PORTON PHARMACEUTICAL LTD.
European Union
European Union
API Registration Country
API Inactive
Recommended Suppliers of Doxazosin mesylate
-
HEFEI LIFEON PHARMACEUTICAL CO., LTD.
CN1 YR
Contact Supplier -
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier -
Shaanxi Dideu Medichem Co. Ltd
CN1 YR
Contact Supplier -
Hainan Flying International Trade Co., L
CN1 YR
Contact Supplier -
Amitychem
CN1 YR
Contact Supplier